1. Home
  2. POLA vs CNSP Comparison

POLA vs CNSP Comparison

Compare POLA & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POLA
  • CNSP
  • Stock Information
  • Founded
  • POLA 1979
  • CNSP 2017
  • Country
  • POLA United States
  • CNSP United States
  • Employees
  • POLA N/A
  • CNSP N/A
  • Industry
  • POLA Industrial Machinery/Components
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • POLA Miscellaneous
  • CNSP Health Care
  • Exchange
  • POLA Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • POLA 8.3M
  • CNSP 6.5M
  • IPO Year
  • POLA 2016
  • CNSP 2019
  • Fundamental
  • Price
  • POLA $2.92
  • CNSP $0.09
  • Analyst Decision
  • POLA
  • CNSP Strong Buy
  • Analyst Count
  • POLA 0
  • CNSP 1
  • Target Price
  • POLA N/A
  • CNSP $0.50
  • AVG Volume (30 Days)
  • POLA 19.2K
  • CNSP 17.2M
  • Earning Date
  • POLA 11-14-2024
  • CNSP 03-31-2025
  • Dividend Yield
  • POLA N/A
  • CNSP N/A
  • EPS Growth
  • POLA N/A
  • CNSP N/A
  • EPS
  • POLA N/A
  • CNSP N/A
  • Revenue
  • POLA $14,953,000.00
  • CNSP N/A
  • Revenue This Year
  • POLA $6.72
  • CNSP N/A
  • Revenue Next Year
  • POLA N/A
  • CNSP N/A
  • P/E Ratio
  • POLA N/A
  • CNSP N/A
  • Revenue Growth
  • POLA N/A
  • CNSP N/A
  • 52 Week Low
  • POLA $2.31
  • CNSP $0.08
  • 52 Week High
  • POLA $4.90
  • CNSP $23.90
  • Technical
  • Relative Strength Index (RSI)
  • POLA 45.18
  • CNSP 37.39
  • Support Level
  • POLA $3.07
  • CNSP $0.09
  • Resistance Level
  • POLA $2.97
  • CNSP $0.10
  • Average True Range (ATR)
  • POLA 0.11
  • CNSP 0.01
  • MACD
  • POLA -0.03
  • CNSP -0.00
  • Stochastic Oscillator
  • POLA 22.22
  • CNSP 26.90

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: